CareDx. which two weeks ago entered into an agreement to acquire ImmuMetrix Inc., has announced that it intends to make an initial public offering (IPO) of common stock with the intent of realizing $50 million. Brisbane, CA–based ...
Organ transplant patients routinely receive drugs that stop their immune systems from attacking newly implanted hearts, livers, kidneys or lungs, which the body sees as foreign. But new research at Washington University School of Medicine ...
Infants and children who undergo heart transplantation are experiencing good outcomes after surgery and may expect to live beyond 15 years post-surgery with reasonable cardiac function and quality of life, according to a study released ...
Tags: Loma Linda, heart transplant, Copeland, post-surgery
More than half of babies and children who receive heart transplants are surviving many years, say the authors of a new study. Pediatric heart transplant patients are living 15 years and longer with good heart function, the scientists ...
Tags: kids, Heart Transplant, Kidney failure, health
Health Highlights: Jan. 13, 2014 Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Nine Womb Transplant Patients Doing Well: Swedish Researchers Nine women who received ...
Tags: Health Highlights, Health
HealthDay Reporter Latest Heart News Fitness in Teen Years Guards Against Heart Trouble Hispanic Women Unaware of Heart Disease Risks Tretten Approved for Genetic Clotting Disorder 'Stress Gene' Might Raise Odds for Heart Attack Warfarin ...
CTCA to be recognized at A.S.P.E.N Conference in January 2014 Cancer Treatment Centers of America® (CTCA) has been recognized by the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) with the organization's ...
Veloxis Pharmaceuticals A/S (OMX: VELO), today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the marketing and sale of Envarsus® (formerly ...
Tags: Veloxis Pharmaceuticals, New Drug Application, Envarsus®
The blood vessels in face transplant patients reorganize themselves after the procedure, researchers report. During a full face transplant, the recipient's major arteries and veins are connected to those in the donor face to ensure ...
Tags: blood vessels, face transplant, face transplant patients c
The US Food and Drug Administration (FDA) has granted orphan drug designation to Conatus Pharmaceuticals' drug candidate emricasan for the treatment of liver transplant patients with reestablished fibrosis to delay the progression to ...
US-based BiologicTx has announced the recent acquisition of Silverstone Solutions and its Kidney Paired Donation software, Silverstone Matchgrid, as part of BiologicTx’s continuing expansion. Silverstone Matchgrid is a sophisticated ...
Tags: BiologicTx, Silverstone Solutions
Adaptive Biotechnologies, a biotechnology company, has secured a $2.5m Phase II small business innovation research (SBIR) award from the National Heart, Lung, and Blood Institute, a division of the NIH. The award is granted to ...
Tags: Adaptive Biotechnologies, Medicine
Pfizer’s Wyeth has consented to pay $491m in fine for unlawful marketing of its kidney drug Rapamune, an FDA-approved immunosuppressant drug used to prevent rejection in organ transplantation. In order to boost Rapamune sales, the ...
Tags: Pfizer Unit, Medicine
The US government has filed a civil fraud lawsuit against Novartis claiming the company made illegal payments to induce pharmacies to switch kidney transplant patients to its immunosuppressant drug Myfortic. Civil fraud lawsuit claimed ...
Tags: Civil Fraud Lawsuit, Health, Healthcare Scam
The USFDA has approved Novartis Zortress as the first drug to prevent organ rejection in adult patients receiving liver transplantation in the US. The approval was based on positive data from liver transplant study that compared Zortress ...
Tags: medication, FDA, Zortress